Evaluation of quality of life in patients with malignant dysphagia

被引:13
作者
Brunelli, C
Mosconi, P
Boeri, P
Gangeri, L
Pizzetti, P
Cerrai, F
Schicchi, A
Apolone, G
Tamburini, M
机构
[1] Ist Nazl Studio & Cura Tumori, I-20133 Milan, Italy
[2] Ist Ric Farmacol Mario Negri, Dipartimento Oncol, Milan, Italy
来源
TUMORI JOURNAL | 2000年 / 86卷 / 02期
关键词
esophageal cancer patients; dysphagia; EORTC QLQ C-30; quality of life;
D O I
10.1177/030089160008600205
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In the last 10 years of clinical research there has been increasing interest In the evaluation of quality of life. Several generic and specific instruments have been developed for this purpose. EORTC QLQ C-30 is a cancer-specific questionnaire translated into Various languages and validated in several European countries including Italy, where the impact of malignant disease on different areas of quality of life is poorly documented. Methods: The EORTC QLQ C-30 was administered to 109 patients referred to the endoscopy division of the Istituto Nazionale Tumori, Milan, for endoscopic palliative treatment of malignant dysphagia to test its characteristics in terms of acceptability and clinical validity. Results: In this group of patients the impact of advanced esophageal cancer was highly evident for Emotional and Physical Functioning, Fatigue and Global QoL scales. Dysphagia is a serious problem for many patients; there is a correlation between grade of dysphagia and four QoL dimensions. Conclusions: QoL assessment is an important tool to evaluate the adequate management of patients with esophageal cancer. The EORTC QLQ-C30 questionnaire proved to be valid and reliable also in this population.
引用
收藏
页码:134 / 138
页数:5
相关论文
共 29 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Aaronson NK., 1996, QUALITY LIFE PHARMAC
  • [3] ANASTASI A, 1988, PSYCHOL TESTING, P84
  • [4] Apolone G, 1998, JAMA-J AM MED ASSOC, V279, P431
  • [5] Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients
    Apolone, G
    Filiberti, A
    Cifani, S
    Ruggiata, R
    Mosconi, P
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (05) : 549 - 557
  • [6] ASTE H, 1985, CANCER, V56, P2713, DOI 10.1002/1097-0142(19851201)56:11<2713::AID-CNCR2820561134>3.0.CO
  • [7] 2-X
  • [8] BARR H, 1991, CANCER, V68, P1660, DOI 10.1002/1097-0142(19911001)68:7<1660::AID-CNCR2820680733>3.0.CO
  • [9] 2-L
  • [10] OBSERVER VARIATION IN ASSESSMENT OF QUALITY-OF-LIFE IN PATIENTS WITH ESOPHAGEAL CANCER
    BLAZEBY, JM
    WILLIAMS, MH
    ALDERSON, D
    FARNDON, JR
    [J]. BRITISH JOURNAL OF SURGERY, 1995, 82 (09) : 1200 - 1203